GSA CAPITAL PARTNERS LLP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$32
-39.6%
34,307
-29.5%
0.00%
-40.0%
Q1 2023$53
-74.3%
48,637
-65.5%
0.01%
-80.8%
Q4 2022$206
-99.9%
141,084
-63.0%
0.03%
-51.9%
Q3 2022$410,000
+186.7%
381,043
+447.4%
0.05%
+184.2%
Q1 2022$143,000
-54.6%
69,612
-17.3%
0.02%
-52.5%
Q4 2021$315,000
-87.4%
84,129
-82.6%
0.04%
-84.3%
Q3 2021$2,506,000
+14.6%
484,782
-5.6%
0.26%
+3.7%
Q2 2021$2,187,000
+342.7%
513,388
+451.4%
0.25%
+200.0%
Q1 2021$494,000
-71.6%
93,112
-71.1%
0.08%
-71.2%
Q4 2020$1,740,000
+194.9%
322,744
+336.5%
0.28%
+190.8%
Q3 2020$590,000
+1034.6%
73,947
+284.8%
0.10%
+653.8%
Q1 2020$52,000
-57.7%
19,219
-81.3%
0.01%
-7.1%
Q4 2019$123,000
+17.1%
102,894
+47.6%
0.01%0.0%
Q3 2019$105,000
-54.7%
69,705
+20.9%
0.01%
-46.2%
Q2 2019$232,000
-21.9%
57,645
-16.6%
0.03%
-13.3%
Q1 2019$297,000
-65.1%
69,109
-9.0%
0.03%
-33.3%
Q1 2018$852,000
+252.1%
75,912
+40.9%
0.04%
+181.2%
Q2 2017$242,000
+191.6%
53,866
+356.4%
0.02%
+300.0%
Q3 2016$83,00011,8030.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$4,903,9392.63%
Syncona Portfolio Ltd 1,377,294$1,074,2891.60%
MPM BioImpact LLC 5,095,912$3,974,8111.06%
NEA Management Company, LLC 17,079,778$13,322,2271.03%
TANG CAPITAL MANAGEMENT LLC 5,166,954$4,030,2240.57%
PFM Health Sciences, LP 10,423,135$8,130,0450.38%
Matrix Capital Management Company, LP 38,974,185$30,399,8640.36%
Long Focus Capital Management, LLC 10,963,158$8,551,2630.31%
Acuitas Investments, LLC 479,764$374,2160.22%
Endurant Capital Management LP 311,944$243,3160.22%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders